<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="100853">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01949259</url>
  </required_header>
  <id_info>
    <org_study_id>Rapid learning lung cancer</org_study_id>
    <nct_id>NCT01949259</nct_id>
  </id_info>
  <brief_title>Rapid Learning for Lung Cancer</brief_title>
  <official_title>Rapid Learning in Practice: A Lung Cancer Survival Decision Support System in Routine Patient Care Data</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht Radiation Oncology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cancer Therapy Center, Liverpool</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Macarthur Cancer Therapy Centres, Liverpool</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ingham Institute Hospital, Liverpool</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NSW, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht Radiation Oncology</source>
  <oversight_info>
    <authority>Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A retrospective, data mining project that re-uses routine patient care data for decision
      support systems.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      By installing tools that extract clinical data from electronic health records and image data
      from the Picture Archiving and Communication System, decision support systems are built and
      validated that can predict survival and treatment toxicities of lung cancer patients treated
      with radiotherapy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>Survival</measure>
    <time_frame>From radiotherapy until death</time_frame>
    <safety_issue>No</safety_issue>
    <description>Retrospective data will be collected from each included patient from start of radiotherapy until end of study or death (an expected average of 10 years).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Local control</measure>
    <time_frame>From start of treatment until death,</time_frame>
    <safety_issue>No</safety_issue>
    <description>Data will be collected from inclusion in the study until end of study of death (an expected average time frame of 10 years) concerning the local control of this tumour.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distant metastases</measure>
    <time_frame>From treatment until end of study</time_frame>
    <safety_issue>No</safety_issue>
    <description>Data concerning the possible occurence of distant metastases will be collected from each patient from inclusion until end of study or date of death (an expected average time frame of 10 years).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea</measure>
    <time_frame>From inclusion until end of study</time_frame>
    <safety_issue>No</safety_issue>
    <description>From each included patient, dyspnea scores will be collected from start of treatment until end of study or date of death (an expected average time frame of 10 years).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dysphagia</measure>
    <time_frame>From treatment until end of study</time_frame>
    <safety_issue>No</safety_issue>
    <description>Dysphagia scores will be collected from each participating patient from treatment until end of study or date of death (an average time frame of 10 years)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Retrospective collection</arm_group_label>
    <description>Retrospective collection of data from included lung cancer patients.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Lung cancer patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Patients notes as suffering from lung cancer in at least one clinical data source.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andre Dekker, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastro Clinic, The Netherlands</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andre Dekker, Dr</last_name>
    <phone>+31 88 44 55 666</phone>
    <email>andre.dekker@maastro.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>MAASTRO clinic</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6229 ET</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andre Dekker, Dr</last_name>
      <phone>+31 88 44 55 666</phone>
      <email>andre.dekker@maastro.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 7, 2014</lastchanged_date>
  <firstreceived_date>September 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Retrospective</keyword>
  <keyword>Lung cancer</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
